Prolactinomas: evolution after menopause

OBJETIVE: The aim was to assess the evolution of tumor size and prolactin (PRL) levels in patients with micro and macroprolactinomas diagnosed and treated with dopamine agonists during fertile age, and the effects of suspension of drugs after menopause. Retrospective study, 29 patients with prolacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallea-Gil, Maria Susana, Manavela, Marcos, Alfieri, Analia, Ballarino, Maria Carolina, Chervin, Alberto, Danilowicz, Karina, Diez, Sabrina, Day, Patricia Fainstein, García-Basavilbaso, Natalia, Glerean, Mariela, Guitelman, Mirtha, Katz, Débora, Loto, Monica Graciela, Martinez, Marcela, Miragaya, Karina, Moncet, Daniel, Rogozinski, Amelia Susana, Servidio, Marisa, Stalldecker, Graciela, Vitale, Marcelo, Boero, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118912/
https://www.ncbi.nlm.nih.gov/pubmed/26909481
http://dx.doi.org/10.1590/2359-3997000000138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118912/
https://www.ncbi.nlm.nih.gov/pubmed/26909481
http://dx.doi.org/10.1590/2359-3997000000138

Ejemplares similares